Qu Biologics Inc.

Recent Finacing

Equity

Recent Raise

$6.7M

Qu Biologics is a clinical-stage biotech developing Site Specific Immunomodulators (SSIs) to restore innate immune responses in targeted organs, advancing multiple Phase 2 programs in cancer and inflammatory diseases.

Founded 2007

British Columbia, Canada

11-50

Private

qubiologics.com

Highlights

Focus Areas

Biotechnology

Health Care

Medical

Recent Investors

Financials

$36.1M

Total Raised

7

Funding rounds

2

Investors

Team

Upgrade to view the team

See the team members at Qu Biologics Inc..